Kura Oncology Inc (KURA)

8.67 -0.31 (-3.45%) USD  |  NASDAQ  |  Dec 27, 16:00
8.65 -0.02 (-0.23%) After-Hours: 20:00
More

Kura Oncology Research and Development Expense (Annual): 115.24M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for KURA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Halozyme Therapeutics Inc 76.36M
AIM ImmunoTech Inc 10.94M
Perspective Therapeutics Inc 21.31M
Protalix BioTherapeutics Inc 17.09M
Armata Pharmaceuticals Inc 33.77M